The first participant has been dosed in a Phase 1 trial testing F230 for the treatment of pulmonary arterial hypertension.

A study of HB-1614 suggests it may improve exercise capacity in adults with pulmonary hypertension associated with ...

Turning 30 is something columnist Anna Jeter never expected to do because of a childhood PH diagnosis. She grapples with the ...

Adding more lines of treatment may reduce the risk of rehospitalization among adults with PAH who are taking only one ...